Skip to main content

Featured

Bioengineering Breakthrough 2025: Gene Editing and the $57 Billion Healthcare Revolution

Bioengineering Breakthrough 2025: Gene Editing and the $57 Billion Healthcare Revolution Bioengineering Breakthrough 2025: Gene Editing and the $57 Billion Healthcare Revolution 🧬 TL;DR - Executive Summary Bioengineering has reached a transformational moment in 2025, with $57.3 billion in investment driving breakthrough gene editing therapies, personalized medicine platforms, and synthetic biology applications. CRISPR-based treatments are achieving remarkable clinical success, while advances in cell therapy, tissue engineering, and precision medicine are revolutionizing healthcare delivery. The convergence of AI, genomics, and bioengineering is creating unprecedented opportunities for investors and patients alike, with the potential to cure previously incurable diseases a...

Walmart Stock: The Unkillable Retail Giant Set to Compound Through 2030 – Why We're Doubling Down Now

Walmart Stock: The Unkillable Retail Giant Set to Compound Through 2030 – Why We're Doubling Down Now

Walmart Stock

The Unkillable Retail Giant.
11% YTD. Q3 Beat. Nasdaq Bound.
And Poised for a Decade of Compounding.

Macfeigh Atunga
CEO & Chief Investment Strategist – The MarketWorth Group
November 20, 2025

I have owned Walmart stock since 2014.
Through the e-commerce wars.
Through the pandemic pivot.
Through the inflation squeeze.

And every single time the world wrote it off as "old retail," we compounded at 18% net.

Today, post-Q3 earnings – 62 cents EPS (beat by 2 cents), $179.5B revenue (beat by $2B) – shares are up 4% premarket to $107.29.
YTD: +11%, outpacing consumer staples.
Analysts: Strong Buy, $114 target (7% upside).

But here's why we're doubling down now: Walmart isn't just surviving. It's evolving into a tech-retail behemoth.

If you want the full thesis on why WMT is our core defensive holding – keep reading.


The Q3 Earnings That Just Lit the Fuse

November 20, 2025. Markets open. Walmart drops the hammer.

Revenue: $179.50B vs. $177.43B expected.
EPS: 62 cents adjusted vs. 60 cents.
U.S. comp sales: +5.3% (grocery +7.1%).
International: +10.8% (Flipkart, China, Mexico crushing it).

Guidance hiked: FY2026 sales +4-5%, EPS $2.68.
And the cherry: Nasdaq listing Dec. 9 – signaling full tech embrace (40% of code now AI-generated).

This isn't a beat. It's a blueprint for 2030 dominance.

Key Metrics (As of Nov 20, 2025)

Current Price: $107.29 (+6.64% today)
Market Cap: $856B
PE Ratio (TTM): 40.49
EPS (TTM): $2.65
Revenue (TTM): $693B
1-Year Return: +24.27%
Analyst Target: $114 (Strong Buy)

Why Walmart's Moat Is Thicker Than Ever in 2025

1. The Trade-Down Tailwind: Value Wins in Uncertainty

Inflation cooled, but consumers are scarred.
Walmart's everyday low prices captured +5.3% U.S. comps.
Grocery (essentials) up 7.1% – while Target cut guidance, Home Depot slashed profits.

Even SNAP pauses didn't dent expedited delivery (via Walmart+).
Low-income shoppers paying for speed? That's pricing power.

2. E-Commerce Explosion: 26% Growth, But It's Just Starting

Walmart+ now rivals Amazon Prime in adoption.
Marketplace sellers: 150K+ (up 20% YoY).
AI-optimized fulfillment: 40% of code AI-assisted.

We're modeling 30% e-comm CAGR through 2028 – turning Walmart from store to platform.

3. International Firepower: 10.8% Growth, Untapped Billions

Flipkart (India): Marketplace king.
Sam's Club (China): Membership boom.
Walmex (Mexico): Border trade accelerator.

20% of revenue, 40% of growth. Emerging markets = Walmart's next flywheel.

4. The Nasdaq Move: Tech Signal, Not Gimmick

Dec. 9: WMT trades on Nasdaq.
Why? Alignment with AI, fintech, cloud ambitions.
40% AI code gen – supply chain oracle spotting disruptions 24 months early.

This isn't cosmetic. It's cultural: Retail-tech hybrid for the AI era.

The CEO Transition: Continuity, Not Chaos

Doug McMillon steps down after 312% returns (vs. Target's 60%, Albertsons' 16%).
John Furner takes over: Ops wizard, tech evangelist.

Handover: Seamless. Strategy: Unchanged.
But acceleration: Full throttle on AI, ads ($4B run-rate), health (Walmart Health clinics scaling).

Markets shrugged – up 0.06% on announcement. We see it as a multi-bagger catalyst.

Valuation: Premium Today, Bargain Tomorrow

PE 40x? High, but forward 32x on $2.68 EPS.
Vs. Amazon (P/S 3x, no dividend), Costco (PE 55x).

Dividend: $0.94 yield, 51-year streak.
Buybacks: $15B authorized.

Our model: 4% sales growth, 6.5% EBIT CAGR = $130 by 2026 end.

Risks: We See Them, But We Don't Fear Them

• Tariffs/Inflation: Grocery buffer (56% sales).
• Amazon Wars: Walmart's physical edge (4,600 stores) + same-day delivery wins.
• Recession: Trade-down accelerates – Walmart thrives in pain.

Doom loop? Not here. Flywheel spinning at full speed.

Investment vs Speculation: Walmart Is Pure Investment

Speculators chase memes. Investors own forever-holds like WMT.

Our full breakdown:

Investment vs Speculation: Why Walmart Builds Dynasties, Not Trades

Frequently Asked Questions

Should I buy Walmart stock now at $107?

Yes. Post-earnings momentum + Nasdaq hype = entry window. Target $114 short-term, $130 2026.

What's the biggest catalyst for WMT in 2026?

AI supply chain + international e-comm. Modeling 15% EPS growth from ads/health.

Is the PE too high?

Forward 32x for 4% growth + 2% yield? No. It's priced for perfection – and Walmart delivers.

How does Walmart compare to Costco/Target?

WMT laps them: 312% 10-year vs. Costco 500% (premium valuation), Target 60%. Broader moat.

Our Position: Doubling Down Today

At The MarketWorth Group, WMT is 8% of the book.
Post-earnings: Adding 3% more.
Thesis: Unbreakable in downturns, explosive in upcycles.

Buy. Hold. Compound.

If this thesis resonates, join the inner circle:

1. Follow The MarketWorth Group on Facebook

2. Follow Macfeigh Atunga – daily stock alpha

3. Subscribe The MarketWorth Group YouTube – weekly deep dives

To compounding that lasts,
Macfeigh Atunga
CEO – The MarketWorth Group

Comments

NYC Stock Market Volatility in 2025 | MarketWorth